Genetic and catalytic efficiency structure of an HCV protease quasispecies

被引:28
作者
Franco, Sandra [1 ]
Parera, Mariona [1 ]
Aparicio, Ester [1 ]
Clotet, Bonaventura [1 ]
Martinez, Miguel Angel [1 ]
机构
[1] Univ Autonoma Barcelona, Fundacio IrsiCaixa, E-08193 Barcelona, Spain
关键词
D O I
10.1002/hep.21623
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The HCV nonstructural protein (NS)3/4A serine protease is not only involved in viral polyprotein processing but also efficiently blocks the retinoic-acid-inducible gen I and Toll-like receptor 3 signaling pathways and contributes to virus persistence by enabling HCV to escape the interferon antiviral response. Therefore, the NS3/4A protcase has emerged as an ideal target for the control of the disease and the development of new anti-HCV agents. Here, we analyzed, at a high resolution (approximately 100 individual clones), the HCV NS3 protease gene quasispecies from three infected individuals. Nucleotide heterogeneity of 49%, 84%, and 91 % were identified, respectively, which created a dense net that linked different parts of the viral population. Minority variants having mutations involved in the acquisition of resistance to current NS3/4A protease inhibitors (PIs) were also found. A vast diversity of different catalytic efficiencies could be distinguished. Importantly, 67% of the analyzed enzymes displayed a detectable protease activity. Moreover, 35% of the minority individual variants showed similar or better catalytic efficiency than the master (most abundant) enzyme. Nevertheless, and in contrast to minority variants, master enzymes always displayed a high catalytic efficiency when different viral polyprotein cleavage sites were tested. Finally, genetic and catalytic efficiency differences were observed when the 3 quasispecies were compared, suggesting that different selective forces were acting in different infected individuals. Conclusion: The rugged HCV protease quasispecies landscape should be able to react to environmental changes that may threaten its survival.
引用
收藏
页码:899 / 910
页数:12
相关论文
共 52 条
[1]   From structure to function: New insights into hepatitis C virus RNA replication [J].
Appel, N ;
Schaller, T ;
Penin, F ;
Bartenschlager, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (15) :9833-9836
[2]   Early HCV dynamics on Peg-interferon and ribavirin in HIV/HCV co-infection:: indications for the investigation of new treatment approaches [J].
Ballesteros, AL ;
Franco, S ;
Fuster, D ;
Planas, R ;
Martínez, MA ;
Acosta, L ;
Sirera, G ;
Salas, A ;
Tor, J ;
Rey-Joly, C ;
Clotet, B ;
Tural, C .
AIDS, 2004, 18 (01) :59-66
[3]   Median-joining networks for inferring intraspecific phylogenies [J].
Bandelt, HJ ;
Forster, P ;
Röhl, A .
MOLECULAR BIOLOGY AND EVOLUTION, 1999, 16 (01) :37-48
[4]   Discovery of SCH446211 (SCH6): A new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication [J].
Bogen, SL ;
Arasappan, A ;
Bennett, F ;
Chen, K ;
Jao, E ;
Liu, YT ;
Lovey, RG ;
Venkatraman, S ;
Pan, WD ;
Parekh, T ;
Pike, RE ;
Ruan, S ;
Liu, R ;
Baroudy, B ;
Agrawal, S ;
Chase, R ;
Ingravallo, P ;
Pichardo, J ;
Prongay, A ;
Brisson, JM ;
Hsieh, TY ;
Cheng, KC ;
Kemp, SJ ;
Levy, OE ;
Lim-Wilby, M ;
Tamura, SY ;
Saksena, AK ;
Girijavallabhan, V ;
Njoroge, FG .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (09) :2750-2757
[5]   Catalytic efficiency and phenotype of HIV-1 proteases encoding single critical resistance substitutions [J].
Cabana, M ;
Fernàndez, G ;
Parera, M ;
Clotet, B ;
Martínez, MA .
VIROLOGY, 2002, 300 (01) :71-78
[6]   GENETIC ORGANIZATION AND DIVERSITY OF THE HEPATITIS-C VIRUS [J].
CHOO, QL ;
RICHMAN, KH ;
HAN, JH ;
BERGER, K ;
LEE, C ;
DONG, C ;
GALLEGOS, C ;
COIT, D ;
MEDINASELBY, A ;
BARR, PJ ;
WEINER, AJ ;
BRADLEY, DW ;
KUO, G ;
HOUGHTON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2451-2455
[7]  
DeLano W. L., 2002, PYMOL
[8]  
Domingo E, 2006, CURR TOP MICROBIOL, V299, P51
[9]   THE QUASISPECIES (EXTREMELY HETEROGENEOUS) NATURE OF VIRAL-RNA GENOME POPULATIONS - BIOLOGICAL RELEVANCE - A REVIEW [J].
DOMINGO, E ;
MARTINEZSALAS, E ;
SOBRINO, F ;
DELATORRE, JC ;
PORTELA, A ;
ORTIN, J ;
LOPEZGALINDEZ, C ;
PEREZBRENA, P ;
VILLANUEVA, N ;
NAJERA, R ;
VANDEPOL, S ;
STEINHAUER, D ;
DEPOLO, N ;
HOLLAND, J .
GENE, 1985, 40 (01) :1-8
[10]   Second locus involved in human immunodeficiency virus type 1 resistance to protease inhibitors [J].
Doyon, L ;
Croteau, G ;
Thibeault, D ;
Poulin, F ;
Pilote, L ;
Lamarre, D .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3763-3769